Target intelligence / Profile preview

Beta-lactoglobulin A (BLG)

Target
BLG
Molecular classification
Lipocalin family, Transporter, Other
01

Overview

Beta-lactoglobulin A is the primary whey protein found in the milk of cows and other ruminants, belonging to the lipocalin family of transport proteins (UniProt: P02754). It is characterized by an eight-stranded, anti-parallel beta-barrel structure that forms a central hydrophobic pocket, which allows it to bind and transport small hydrophobic molecules such as retinol and fatty acids (PubMed: 10998255). While it serves as a major source of amino acids for the neonate, it is absent in human milk, making it a potent foreign antigen in humans. Consequently, Beta-lactoglobulin A (clinically known as Bos d 5) is a major allergen responsible for cow's milk protein allergy (CMPA), particularly in infants and young children (Allergome: Bos d 5). It is not a traditional therapeutic target for drug inhibition; instead, it is utilized in diagnostic assays and as the active component in oral immunotherapy (OIT) protocols designed to induce desensitization and clinical tolerance in allergic patients (PubMed: 28641963). Additionally, its robust structure makes it a subject of research for the encapsulation and delivery of hydrophobic nutraceuticals.

Other names
Bos d 5LGBBeta-LGWhey protein variant A
02

Mechanism of action

Induction of immune tolerance through allergen-specific immunotherapy (desensitization), which shifts the immune response from a Th2-mediated allergic profile to a Treg and Th1-mediated tolerant profile, often characterized by increased allergen-specific IgG4.

03

Biological functions

Hydrophobic molecule transportRetinol bindingFatty acid bindingNutrient deliveryOther
04

Disease associations

Cow's milk protein allergyFood allergyAnaphylaxisOther
05

Safety considerations

AnaphylaxisSevere systemic allergic reactionsCross-reactivity with other mammalian milk proteins
06

Interacting drugs

Milk (cow) Allergen Extract
07

Biomarkers

Bos d 5-specific IgESkin prick test reactivityBasophil activation test (BAT)

Beyond the preview

Go deeper on Beta-lactoglobulin A (BLG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-lactoglobulin A (BLG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call